Condition

Peripheral Vascular Disease

ClinicalTrials.gov condition label

Clinical trials26
Recruiting0
Common interventions25
Lead sponsors shown15

Clinical trials

26 shown
Mobility Assessment in Multi-morbidityNCT06473168 · 2024-12-01
UNKNOWN
Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?NCT05804097 · 2021-10-08
ACTIVE_NOT_RECRUITING
Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)NCT04283994 · 2021-07-26
COMPLETED
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)NCT04281784 · 2020-04-23
COMPLETED
Project to Improve Communication About Serious Illness - Pilot StudyNCT03746392 · 2018-07-01
COMPLETED
Autologous Transplantation of BM-ECs With Platelet-Rich Plasma Extract for the Treatment of Critical Limb IschemiaNCT02993809 · 2018-03-01
UNKNOWN
Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular ComplicationsNCT02834858 · 2016-01-01
UNKNOWN
A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular ComplicationsNCT02796079 · 2015-01-01
UNKNOWN
A Clinical Study Using Adipose-derived Stem Cells for Diabetic FootNCT02831075 · 2015-01-01
UNKNOWN
Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia TreatingNCT01903044 · 2014-09-01
UNKNOWN
Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin SitesNCT01983215 · 2013-04-01
UNKNOWN
Open-label Pilot Study to Assess the Use of Magic Foot™ in the Improvment of Parameters in Subject With Foot SymptomsNCT01784471 · 2012-11-01
COMPLETED
PF-00489791 For The Treatment Of Raynaud'sNCT01090492 · 2010-08-04
COMPLETED
Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without PottasiumNCT01404078 · 2010-04-01
COMPLETED
Safety Study of MultiGeneAngio in Patients With Chronic Critical Limb IschemiaNCT00956332 · 2010-02-01
UNKNOWN
Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral AngioplastyNCT01150617 · 2008-12-01
TERMINATED
Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening IschemiaNCT00434616 · 2007-04-01
UNKNOWN
The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without DiabetesNCT00456105 · 2006-07-01
TERMINATED
Testosterone for Peripheral Vascular DiseaseNCT00504712 · 2006-02-01
COMPLETED
Testosterone Replacement in Diabetes With Vascular Disease (Version 2)NCT00355537 · 2006-02-01
COMPLETED
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)NCT00574782 · 2003-09-01
COMPLETED
Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)NCT00660764 · 2003-05-01
COMPLETED
Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)NCT00442845 · 2003-01-01
COMPLETED
Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol TargetsNCT00442325 · 2003-01-01
COMPLETED
Association of Long-term Conditions With Survival Following Heart Attack in England and WalesNCT03037255 · 2003-01-01
COMPLETED
Registry of Cardiovascular Disease PatientsNCT01759225 · 1998-01-01
ENROLLING_BY_INVITATION

Common interventions

salineBIOLOGICAL3Atorvastatin (Lipitor)DRUG2EHR-based Clinician JumpstartBEHAVIORAL2TestosteroneDRUG20.9% salineDRUG1Adipose-derived stem cellBIOLOGICAL1Autologous bone marrow cell concentrate transplantationPROCEDURE1BM-ECsBIOLOGICAL1BM-ECs and PRPEBIOLOGICAL1BM-MNC injectionPROCEDURE1Double dose PolycapDRUG1Hyperbaric oxygenDRUG1Insulin glargine plus insulin analoguesDRUG1Jumpstart InterventionBEHAVIORAL1long term conditionsOTHER1Magic Foot™DEVICE1mesenchymal stem cellsBIOLOGICAL1MultiGeneAngioBIOLOGICAL1PF-00489791DRUG1Prevena vacDEVICE1RosuvastatinDRUG1salineDRUG1saline injectionBIOLOGICAL1Single Dose PolycapDRUG1Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive diabetes care under the direction of the Diabetes Action TeamBEHAVIORAL1

Trial status mix

COMPLETED13
UNKNOWN9
TERMINATED2
ACTIVE_NOT_RECRUITING1
ENROLLING_BY_INVITATION1

Phase mix

NA7
PHASE16
PHASE46
PHASE24
PHASE31

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.